IVD Medical Holding Limited (1931.HK)

1.000 +0.110 (+12.36%) At close: 03:57PM HKT

IVD Medical Holding Limited

Building 6
Room 602, Lane 299 Bisheng Road Zhangjiang Hi-Tech Park, Pudong New Area
Shanghai
China

https://www.ivdholding.com

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 803

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kuk Sing Ho	Chairman & CEO	4.07M	N/A	1960
Mr. Xianya Lin	GM & Executive Director	2.37M	N/A	1977
Mr. Kim Fai Law	CFO, Joint Company Secretary & Executive Director	N/A	N/A	1971
Mr. Siu Kei Ken Chan	Executive Director	N/A	N/A	1984
Mr. Bo Yang	Financial Controller	N/A	N/A	1979
Ms. Wai Yan Lam	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analyzers and reagents. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. IVD Medical Holding Limited was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.

Corporate governance

IVD Medical Holding Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.